The FDA has approved guselkumab (Tremfya) as the first IL-23 inhibitor offering both subcutaneous and intravenous induction options for adults with moderate to severe active Crohn disease.
As people get out to clean up their yards, either getting it ready for spring or cleaning up after a spring storm, they often ...
FORGET a six-pack, do you just long for the day when you can do up your jeans without performing a gymnastics routine worthy ...
Investor's Business Daily on MSN9h
Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBioAlnylam stock jumped Friday after the drugmaker won a second Food and Drug Administration approval for its drug, Amvuttra.
Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...
Medtronic’s VenaSeal Spectrum postmarket clinical trial program is highlighting the need for further patient-centric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback